You are here

Luye Pharma, owners eye up to US$764m from HK IPO

Drugmaker selling shares after 2012 delisting from SGX

[SINGAPORE] Luye Pharma Group Ltd, a Chinese drugmaker backed by Singapore's sovereign wealth fund, and existing owners are seeking to raise as much as US$764 million from a Hong Kong initial public offering.The company and its investors are selling 999.6 million shares at HK$5.38 to HK$5.92

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom